Effect of Myrtus communis syrup in treatment of Functional Dyspepsia

Formulation and evaluation of the efficacy of Myrtus communis syrup in patients with Functional Dyspepsia, A randomized double bind controlled clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231005059633N1

Enrollment

Registered

2023-11-04

Start date

2023-11-11

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia. Other specified diseases of stomach and duodenum

Interventions

Intervention 1: Intervention group: For one month, they are treated with the fruit syrup of the plant in the amount of 5 cc per day along with 2 standard medicines (Dimethicone 40) per day. Interventi

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age should be more than 18 years and less than 80 years Body mass index should be between 18 and 35 height per square meter The patient has not been treated with myrtus communis syrup in the past month The disease is suffering from dyspepsia whose type of disease is fully confirmed through complete medical examination, pathology and laboratory information

Exclusion criteria

Exclusion criteria: cancer patients

Design outcomes

Primary

Measure	Time frame
Flatulence. Timepoint: at the beginning of the study (before the intervention) and at the end of the study (after one month). Method of measurement: Questionnaire.;Stomach pain. Timepoint: at the beginning of the study (before the intervention) and at the end of the study (after one month). Method of measurement: Questionnaire.;Nausea. Timepoint: at the beginning of the study (before the intervention) and at the end of the study (after one month). Method of measurement: Questionnaire.;Esophagitis. Timepoint: at the beginning of the study (before the intervention) and at the end of the study (after one month). Method of measurement: Questionnaire.	—

Measure

Time frame

Flatulence. Timepoint: at the beginning of the study (before the intervention) and at the end of the study (after one month). Method of measurement: Questionnaire.;Stomach pain. Timepoint: at the beginning of the study (before the intervention) and at the end of the study (after one month). Method of measurement: Questionnaire.;Nausea. Timepoint: at the beginning of the study (before the intervention) and at the end of the study (after one month). Method of measurement: Questionnaire.;Esophagitis. Timepoint: at the beginning of the study (before the intervention) and at the end of the study (after one month). Method of measurement: Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNegin Najafi

Kermanshah University of Medical Sciences

najafi.ne1998@gmail.com+98 993 120 0943

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026